-- 
Teva Advances Most in 3 Months on Venture With Procter & Gamble

-- B y   R o n i t   G o o d m a n
-- 
2011-03-24T14:45:17Z

-- http://www.bloomberg.com/news/2011-03-24/teva-advances-most-in-3-months-on-venture-with-procter-gamble.html
Teva Pharmaceutical Industries Ltd. (TEVA) 
climbed the most in almost three months after the worldâ€™s
largest maker of generic drugs agreed to form a consumer-health
venture with  Procter & Gamble Co. (PG)   The shares advanced 3.4 percent, the biggest increase since
Jan. 9, to 178.60 shekels at the 4:30 p.m. close in Tel Aviv.  The two companies will combine their consumer-health
businesses outside North America in a joint venture that aims to
capture more of the $200 billion market for over-the-counter
medicines.  To contact the reporter on this story:
Ronit Goodman in Tel Aviv at 
 rgoodman9@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  